Investing in OTC biotechnology is a rocky adventur
Post# of 30028
Quote:
Investing in OTC biotechnology is a rocky adventure, and certainly there will be peaks and valleys along the way. We believe we are well positioned from a pipeline and capital availability standpoint to weather the current valley and allow shareholders to benefit from the peaks our pipeline may create. We continue to believe in our pipeline, our people and our prospects, and look forward to moving forward hand in hand with our shareholders as we take the incremental steps necessary to unlock the true value from our pipeline.